Regulation of multidrug resistance in pathogenic fungi.
暂无分享,去创建一个
[1] C. Bauser,et al. Functional Analysis of cis- and trans-Acting Elements of the Candida albicans CDR2 Promoter with a Novel Promoter Reporter System , 2009, Eukaryotic Cell.
[2] A. Sellam,et al. Role of Ndt80p in Sterol Metabolism Regulation and Azole Resistance in Candida albicans , 2009, Eukaryotic Cell.
[3] B. Da Silva,et al. Nonsense and Missense Mutations in FCY2 and FCY1 Genes Are Responsible for Flucytosine Resistance and Flucytosine-Fluconazole Cross-Resistance in Clinical Isolates of Candida lusitaniae , 2009, Antimicrobial Agents and Chemotherapy.
[4] G. Boucher,et al. Identification of the Candida albicans Cap1p Regulon , 2009, Eukaryotic Cell.
[5] J. Piškur,et al. Formation of new chromosomes as a virulence mechanism in yeast Candida glabrata , 2009, Proceedings of the National Academy of Sciences.
[6] M. Raymond,et al. Relative Contributions of the Candida albicans ABC Transporters Cdr1p and Cdr2p to Clinical Azole Resistance , 2009, Antimicrobial Agents and Chemotherapy.
[7] G. Fadda,et al. Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence , 2009, PLoS pathogens.
[8] D. Choudhury,et al. MFS transportome of the human pathogenic yeast Candida albicans , 2008, BMC Genomics.
[9] Lan Yan,et al. DNA microarray analysis of fluconazole resistance in a laboratory Candida albicans strain. , 2008, Acta biochimica et biophysica Sinica.
[10] R. Cannon,et al. Abc1p Is a Multidrug Efflux Transporter That Tips the Balance in Favor of Innate Azole Resistance in Candida krusei , 2008, Antimicrobial Agents and Chemotherapy.
[11] Martin Bard,et al. A Sterol-Regulatory Element Binding Protein Is Required for Cell Polarity, Hypoxia Adaptation, Azole Drug Resistance, and Virulence in Aspergillus fumigatus , 2008, PLoS pathogens.
[12] P. D. Rogers,et al. Gain-of-Function Mutations in the Transcription Factor MRR1 Are Responsible for Overexpression of the MDR1 Efflux Pump in Fluconazole-Resistant Candida dubliniensis Strains , 2008, Antimicrobial Agents and Chemotherapy.
[13] J. Morschhäuser,et al. Mutations in the multi‐drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans strains , 2008, Molecular microbiology.
[14] R. Homayouni,et al. A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate , 2008, Eukaryotic Cell.
[15] M. Ramsdale,et al. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae. , 2008, Microbiology.
[16] J. Berman,et al. An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1 , 2008, Molecular microbiology.
[17] T. C. White,et al. Characterization of caspofungin susceptibilities by broth and agar in Candida albicans clinical isolates with characterized mechanisms of azole resistance. , 2008, Medical mycology.
[18] K. Struhl,et al. A nuclear receptor-like pathway regulating multidrug resistance in fungi , 2008, Nature.
[19] G. Fadda,et al. The ATP‐binding cassette transporter–encoding gene CgSNQ2 is contributing to the CgPDR1‐dependent azole resistance of Candida glabrata , 2008, Molecular microbiology.
[20] M. Treiber,et al. Rifampicin induces MDR1 expression in Candida albicans. , 2008, The Journal of antimicrobial chemotherapy.
[21] R. Prasad,et al. Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression of CDR1 in Azole-Resistant Candida albicans , 2008, Antimicrobial Agents and Chemotherapy.
[22] Hao Li,et al. The Evolution of Combinatorial Gene Regulation in Fungi , 2008, PLoS biology.
[23] A. Stringaro,et al. Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans , 2008, Antimicrobial Agents and Chemotherapy.
[24] J. Yates,et al. CTA4 Transcription Factor Mediates Induction of Nitrosative Stress Response in Candida albicans , 2007, Eukaryotic Cell.
[25] R. Homayouni,et al. The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans , 2007, PLoS pathogens.
[26] Sadri Znaidi,et al. The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans , 2007, Molecular microbiology.
[27] R. Homayouni,et al. Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon , 2007, Eukaryotic Cell.
[28] Kailash Gulshan,et al. Multidrug Resistance in Fungi , 2007, Eukaryotic Cell.
[29] D. Diogo,et al. Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates , 2007, Eukaryotic Cell.
[30] D. Perlin. Resistance to echinocandin-class antifungal drugs. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[31] Y. Uehara,et al. Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae , 2007, Eukaryotic Cell.
[32] R. Prasad,et al. Voriconazole and multidrug resistance in Candida albicans , 2007, Mycoses.
[33] J. Bennett,et al. The bZip transcription factor Cgap1p is involved in multidrug resistance and required for activation of multidrug transporter gene CgFLR1 in Candida glabrata. , 2007, Gene.
[34] C. Hennequin,et al. Reduced Susceptibility to Polyenes Associated with a Missense Mutation in the ERG6 Gene in a Clinical Isolate of Candida glabrata with Pseudohyphal Growth , 2006, Antimicrobial Agents and Chemotherapy.
[35] D. Sanglard,et al. Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance. , 2006, Microbiology.
[36] J. Villard,et al. Molecular Mechanism of Flucytosine Resistance in Candida lusitaniae: Contribution of the FCY2, FCY1, and FUR1 Genes to 5-Fluorouracil and Fluconazole Cross-Resistance , 2006, Antimicrobial Agents and Chemotherapy.
[37] C. Kumamoto,et al. Transcriptional Regulation of MDR1, Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding Site , 2006, Eukaryotic Cell.
[38] B. Turcotte,et al. A Fungal Family of Transcriptional Regulators: the Zinc Cluster Proteins , 2006, Microbiology and Molecular Biology Reviews.
[39] R. Homayouni,et al. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome‐wide expression studies , 2006, Molecular microbiology.
[40] J. Berman,et al. Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans , 2006, Science.
[41] J. Morschhäuser,et al. Multiple cis-Acting Sequences Mediate Upregulation of the MDR1 Efflux Pump in a Fluconazole-Resistant Clinical Candida albicans Isolate , 2006, Antimicrobial Agents and Chemotherapy.
[42] M. Raymond,et al. PDR16‐mediated azole resistance in Candida albicans , 2006, Molecular microbiology.
[43] J. Berman,et al. A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans , 2006, Genetics.
[44] J. Bennett,et al. Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants , 2006, Antimicrobial Agents and Chemotherapy.
[45] D. Sanglard,et al. Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans , 2006, Antimicrobial Agents and Chemotherapy.
[46] R. Cannon,et al. Overexpression of Candida albicans CDR1, CDR2, or MDR1 Does Not Produce Significant Changes in Echinocandin Susceptibility , 2006, Antimicrobial Agents and Chemotherapy.
[47] G. Fadda,et al. Role of AFR1, an ABC Transporter-Encoding Gene, in the In Vivo Response to Fluconazole and Virulence of Cryptococcus neoformans , 2006, Infection and Immunity.
[48] D. Choudhury,et al. Complete Inventory of ABC Proteins in Human Pathogenic Yeast, Candida albicans , 2005, Journal of Molecular Microbiology and Biotechnology.
[49] F. Dalle,et al. Biological consequences of petite mutations in Candida glabrata. , 2005, The Journal of antimicrobial chemotherapy.
[50] R. Vishwakarma,et al. Functional Analysis of CaIPT1, a Sphingolipid Biosynthetic Gene Involved in Multidrug Resistance and Morphogenesis of Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.
[51] W. Moye-Rowley. Retrograde regulation of multidrug resistance in Saccharomyces cerevisiae. , 2005, Gene.
[52] T. C. White,et al. Drug-Induced Regulation of the MDR1 Promoter in Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.
[53] R. Prasad,et al. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element. , 2005, Biochemical and biophysical research communications.
[54] R. Homayouni,et al. Genome-Wide Expression Profiling of the Response to Azole, Polyene, Echinocandin, and Pyrimidine Antifungal Agents in Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.
[55] A. Mitchell,et al. Regulation of azole drug susceptibility by Candida albicans protein kinase CK2 , 2005, Molecular microbiology.
[56] S. Kelly,et al. Reduced Azole Susceptibility in Genotype 3 Candida dubliniensis Isolates Associated with Increased CdCDR1 and CdCDR2 Expression , 2005, Antimicrobial Agents and Chemotherapy.
[57] G. Fadda,et al. Mechanisms of Azole Resistance in Clinical Isolates of Candida glabrata Collected during a Hospital Survey of Antifungal Resistance , 2005, Antimicrobial Agents and Chemotherapy.
[58] B. Arthington-Skaggs,et al. Rapid Acquisition of Stable Azole Resistance by Candida glabrata Isolates Obtained before the Clinical Introduction of Fluconazole , 2005, Antimicrobial Agents and Chemotherapy.
[59] T. Edlind,et al. Effects of Cetylpyridinium Chloride Resistance and Treatment on Fluconazole Activity versus Candida albicans , 2005, Antimicrobial Agents and Chemotherapy.
[60] J. Vazquez,et al. Multiechinocandin- and Multiazole-Resistant Candida parapsilosis Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis , 2005, Antimicrobial Agents and Chemotherapy.
[61] D. Sanglard,et al. TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2 , 2004, Eukaryotic Cell.
[62] Y. Uehara,et al. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance. , 2004, The Journal of antimicrobial chemotherapy.
[63] Yun-Liang Yang,et al. CaNdt80 Is Involved in Drug Resistance in Candida albicans by Regulating CDR1 , 2004, Antimicrobial Agents and Chemotherapy.
[64] L. Tabernero,et al. Molecular Mechanisms of Primary Resistance to Flucytosine in Candida albicans , 2004, Antimicrobial Agents and Chemotherapy.
[65] G. Goldman,et al. In Vitro Evolution of Itraconazole Resistance in Aspergillus fumigatus Involves Multiple Mechanisms of Resistance , 2004, Antimicrobial Agents and Chemotherapy.
[66] T. Edlind,et al. Azole Resistance in Candida glabrata: Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor , 2004, Antimicrobial Agents and Chemotherapy.
[67] G. Goldman,et al. Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in Brazil. , 2004, Diagnostic microbiology and infectious disease.
[68] Alix T. Coste,et al. Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug Transporters , 2004, Antimicrobial Agents and Chemotherapy.
[69] D. Soll,et al. Clade-Specific Flucytosine Resistance Is Due to a Single Nucleotide Change in the FUR1 Gene of Candida albicans , 2004, Antimicrobial Agents and Chemotherapy.
[70] P. Poupard,et al. Mechanisms of Azole Resistance in Petite Mutants of Candida glabrata , 2004, Antimicrobial Agents and Chemotherapy.
[71] K. Marr,et al. Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis , 2004, Antimicrobial Agents and Chemotherapy.
[72] B. Cormack,et al. Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata: Roles of Calcium Signaling and Mitochondria , 2004, Antimicrobial Agents and Chemotherapy.
[73] R. Prasad,et al. Membrane Sphingolipid-Ergosterol Interactions Are Important Determinants of Multidrug Resistance in Candida albicans , 2004, Antimicrobial Agents and Chemotherapy.
[74] Steve A. Hernandez,et al. Caspofungin Resistance in Candida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis , 2004, Antimicrobial Agents and Chemotherapy.
[75] J. Sobel,et al. Shuttle vectors for Candida albicans: control of plasmid copy number and elevated expression of cloned genes , 2004, Current Genetics.
[76] N. Karnani,et al. SRE1 and SRE2 are two specific steroid‐responsive modules of Candida drug resistance gene 1 (CDR1) promoter , 2004, Yeast.
[77] Mi-Kyung Lee,et al. Drug resistance genes and trailing growth in Candida albicans isolates. , 2004, The Journal of antimicrobial chemotherapy.
[78] T. Edlind,et al. Cyclic AMP Signaling Pathway Modulates Susceptibility of Candida Species and Saccharomyces cerevisiae to Antifungal Azoles and Other Sterol Biosynthesis Inhibitors , 2003, Antimicrobial Agents and Chemotherapy.
[79] J. Heitman,et al. Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B in Candida lusitaniae , 2003, Antimicrobial Agents and Chemotherapy.
[80] M. Raymond,et al. Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters , 2003, Antimicrobial Agents and Chemotherapy.
[81] G. Goldman,et al. Multiple Resistance Mechanisms among Aspergillus fumigatus Mutants with High-Level Resistance to Itraconazole , 2003, Antimicrobial Agents and Chemotherapy.
[82] K. Kuchler,et al. The Candida albicans Cdr2p ATP‐binding cassette (ABC) transporter confers resistance to caspofungin , 2003, Molecular microbiology.
[83] P. Paumard,et al. Flucytosine-Fluconazole Cross-Resistance in Purine-Cytosine Permease-Deficient Candida lusitaniae Clinical Isolates: Indirect Evidence of a Fluconazole Uptake Transporter , 2003, Antimicrobial Agents and Chemotherapy.
[84] J. Bennett,et al. Function of Candida glabrata ABC transporter gene, PDH1 , 2003, Yeast.
[85] H. Brunner,et al. A screen in Saccharomyces cerevisiae identified CaMCM1, an essential gene in Candida albicans crucial for morphogenesis , 2003, Molecular microbiology.
[86] J. Lopez-Ribot,et al. Multiple Patterns of Resistance to Fluconazole in Candida glabrata Isolates from a Patient with Oropharyngeal Candidiasis Receiving Head and Neck Radiation , 2003, Journal of Clinical Microbiology.
[87] G. Fadda,et al. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter‐encoding gene, CnAFR1, involved in the resistance to fluconazole , 2003, Molecular microbiology.
[88] Y. Uehara,et al. Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[89] R. Skurray,et al. Regulation of Bacterial Drug Export Systems , 2002, Microbiology and Molecular Biology Reviews.
[90] Y. Uehara,et al. Candida glabrata ATP-binding Cassette Transporters Cdr1p and Pdh1p Expressed in aSaccharomyces cerevisiae Strain Deficient in Membrane Transporters Show Phosphorylation-dependent Pumping Properties* , 2002, The Journal of Biological Chemistry.
[91] T. Edlind,et al. Histone Deacetylase Inhibitors Enhance Candida albicans Sensitivity to Azoles and Related Antifungals: Correlation with Reduction in CDR and ERG Upregulation , 2002, Antimicrobial Agents and Chemotherapy.
[92] J. Morschhäuser,et al. The Candida dubliniensis CdCDR1 Gene Is Not Essential for Fluconazole Resistance , 2002, Antimicrobial Agents and Chemotherapy.
[93] D. Denning,et al. Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. , 2002, Fungal genetics and biology : FG & B.
[94] J. Morschhäuser. The genetic basis of fluconazole resistance development in Candida albicans. , 2002, Biochimica et biophysica acta.
[95] B. Wickes,et al. Molecular Mechanisms of Fluconazole Resistance in Candida dubliniensis Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis , 2002, Antimicrobial Agents and Chemotherapy.
[96] R. Prasad,et al. In Vitro Low-Level Resistance to Azoles in Candida albicans Is Associated with Changes in Membrane Lipid Fluidity and Asymmetry , 2002, Antimicrobial Agents and Chemotherapy.
[97] T. C. White,et al. Homozygosity at the Candida albicans MTL locus associated with azole resistance. , 2002, Microbiology.
[98] Smriti,et al. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators , 2002, Yeast.
[99] J. Lopez-Ribot,et al. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis. , 2002, The Journal of antimicrobial chemotherapy.
[100] D. Sanglard,et al. A common drug‐responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance , 2002, Molecular microbiology.
[101] J. Morschhäuser,et al. MDR1-Mediated Drug Resistance inCandida dubliniensis , 2001, Antimicrobial Agents and Chemotherapy.
[102] J. Lopez-Ribot,et al. Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients , 2001, Antimicrobial Agents and Chemotherapy.
[103] M. Raymond,et al. Functional isolation of the Candida albicans FCR3 gene encoding a bZip transcription factor homologous to Saccharomyces cerevisiae Yap3p , 2001, Yeast.
[104] Xiao-Jun Ma,et al. Genomic Profiling of the Response of Candida albicans to Itraconazole Treatment Using a DNA Microarray , 2001, Antimicrobial Agents and Chemotherapy.
[105] D. Sanglard,et al. Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata , 2001, Antimicrobial Agents and Chemotherapy.
[106] S. Katiyar,et al. Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei. , 2001, Medical mycology.
[107] T. C. White,et al. Inducible Azole Resistance Associated with a Heterogeneous Phenotype in Candida albicans , 2001, Antimicrobial Agents and Chemotherapy.
[108] R. Filmon,et al. In-vivo selection of an azole-resistant petite mutant of Candida glabrata. , 2000, Journal of Medical Microbiology.
[109] D. Sanglard,et al. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. , 2000, Microbiology.
[110] T. C. White,et al. Transcriptional Analyses of Antifungal Drug Resistance in Candida albicans , 2000, Antimicrobial Agents and Chemotherapy.
[111] D. Sanglard,et al. Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750 , 2000, Antimicrobial Agents and Chemotherapy.
[112] H. Schoonbeek,et al. Fungal transporters involved in efflux of natural toxic compounds and fungicides. , 2000, Fungal genetics and biology : FG & B.
[113] J. Morschhäuser,et al. Targeted gene disruption in Candida albicans wild‐type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates , 2000, Molecular microbiology.
[114] D. Sanglard,et al. Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p , 2000, Molecular microbiology.
[115] L. Cowen,et al. Evolution of Drug Resistance in Experimental Populations of Candida albicans , 2000, Journal of bacteriology.
[116] G. Köhler,et al. Activation of the Multiple Drug Resistance GeneMDR1 in Fluconazole-Resistant, Clinical Candida albicans Strains Is Caused by Mutations in atrans-Regulatory Factor , 2000, Journal of bacteriology.
[117] T. C. White,et al. The R467K Amino Acid Substitution in Candida albicans Sterol 14α-Demethylase Causes Drug Resistance through Reduced Affinity , 2000, Antimicrobial Agents and Chemotherapy.
[118] D. Kelly,et al. Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem. , 1999, FEMS microbiology letters.
[119] D. Sanglard,et al. The ATP Binding Cassette Transporter GeneCgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents , 1999, Antimicrobial Agents and Chemotherapy.
[120] R. V. Prasad,et al. CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole. , 1999, FEMS microbiology letters.
[121] M. Ghannoum,et al. Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance , 1999, Clinical Microbiology Reviews.
[122] J. Morschhäuser,et al. Molecular aspects of fluconazole resistance development in Candida albicans , 1999, Mycoses.
[123] D. Kelly,et al. The G464S amino acid substitution in Candida albicans sterol 14alpha-demethylase causes fluconazole resistance in the clinic through reduced affinity. , 1999, Biochemical and biophysical research communications.
[124] S. Katiyar,et al. Antagonism of Azole Activity against Candida albicans following Induction of Multidrug Resistance Genes by Selected Antimicrobial Agents , 1999, Antimicrobial Agents and Chemotherapy.
[125] J. Lopez-Ribot,et al. Multiple Resistant Phenotypes of Candida albicansCoexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients , 1999, Antimicrobial Agents and Chemotherapy.
[126] P. Staib,et al. Sequential gene disruption in Candida albicans by FLP‐mediated site‐specific recombination , 1999, Molecular microbiology.
[127] M. Raymond,et al. The bZip Transcription Factor Cap1p Is Involved in Multidrug Resistance and Oxidative Stress Response inCandida albicans , 1999, Journal of bacteriology.
[128] V. Gupta,et al. Asymmetric distribution of phosphatidylethanolamine in C. albicans : possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily , 1999, Yeast.
[129] A. Goffeau,et al. PDR16 and PDR17, Two Homologous Genes ofSaccharomyces cerevisiae, Affect Lipid Biosynthesis and Resistance to Multiple Drugs* , 1999, The Journal of Biological Chemistry.
[130] M. Raymond,et al. Isolation of a Putative Candida albicansTranscriptional Regulator Involved in Pleiotropic Drug Resistance by Functional Complementation of a pdr1 pdr3 Mutation inSaccharomyces cerevisiae , 1999, Journal of bacteriology.
[131] L H Lee,et al. Crm1p mediates regulated nuclear export of a yeast AP‐1‐like transcription factor , 1998, The EMBO journal.
[132] D. Kelly,et al. Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans Strains , 1998, Antimicrobial Agents and Chemotherapy.
[133] T. C. White,et al. Distinct Patterns of Gene Expression Associated with Development of Fluconazole Resistance in Serial Candida albicansIsolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis , 1998, Antimicrobial Agents and Chemotherapy.
[134] J. Morschhäuser,et al. A fourth gene from the Candida albicans CDR family of ABC transporters. , 1998, Gene.
[135] T. C. White,et al. Rapid, Transient Fluconazole Resistance inCandida albicans Is Associated with Increased mRNA Levels of CDR , 1998, Antimicrobial Agents and Chemotherapy.
[136] M. Ghannoum,et al. Mechanism of Fluconazole Resistance inCandida krusei , 1998, Antimicrobial Agents and Chemotherapy.
[137] V. Gupta,et al. Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation , 1998, Current Genetics.
[138] S. Donnelly,et al. Identification and Expression of Multidrug Transporters Responsible for Fluconazole Resistance in Candida dubliniensis , 1998, Antimicrobial Agents and Chemotherapy.
[139] D. Ward,et al. Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1, inCandida glabrata , 1998, Antimicrobial Agents and Chemotherapy.
[140] C. Nombela,et al. Induced expression of the Candida albicans multidrug resistance gene CDR1 in response to fluconazole and other antifungals , 1998, Yeast.
[141] R. V. Prasad,et al. Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs and human steroid hormones. , 1998, FEMS microbiology letters.
[142] Dominique Sanglard,et al. Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents , 1998, Antimicrobial Agents and Chemotherapy.
[143] M. Raymond,et al. The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter , 1997, Journal of bacteriology.
[144] P. Skatrud,et al. Cloning and characterization of CneMDR1: a Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins. , 1997, Gene.
[145] P. Skatrud,et al. Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus. , 1997, Gene.
[146] A. Goffeau,et al. Active efflux by multidrug transporters as one of the strategies to evade chemotherapy and novel practical implications of yeast pleiotropic drug resistance. , 1997, Pharmacology & therapeutics.
[147] C. van Broeckhoven,et al. Molecular biological characterization of an azole-resistant Candida glabrata isolate , 1997, Antimicrobial agents and chemotherapy.
[148] M. Raymond,et al. AP1-mediated Multidrug Resistance in Saccharomyces cerevisiae Requires FLR1 Encoding a Transporter of the Major Facilitator Superfamily* , 1997, The Journal of Biological Chemistry.
[149] T. C. White,et al. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus , 1997, Antimicrobial agents and chemotherapy.
[150] D. Kelly,et al. Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363. , 1997, FEMS microbiology letters.
[151] D. Sanglard,et al. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. , 1997, Microbiology.
[152] D. Kelly,et al. Resistance to fluconazole and cross‐resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6‐desaturation , 1997, FEBS letters.
[153] J. Wingard,et al. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia , 1997, Antimicrobial agents and chemotherapy.
[154] R. Cannon,et al. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance , 1996, Antimicrobial agents and chemotherapy.
[155] S. Kelly,et al. Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance , 1996, Antimicrobial agents and chemotherapy.
[156] D. Sanglard,et al. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors , 1996, Antimicrobial agents and chemotherapy.
[157] N. Gow,et al. Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance , 1996, Antimicrobial agents and chemotherapy.
[158] K. Kuchler,et al. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters , 1995, Antimicrobial agents and chemotherapy.
[159] S. Kelly,et al. Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. , 1995, FEMS microbiology letters.
[160] T. Parkinson,et al. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata , 1995, Antimicrobial agents and chemotherapy.
[161] S. Kelly,et al. Cross-resistance to polyene and azole drugs in Cryptococcus neoformans , 1995, Antimicrobial agents and chemotherapy.
[162] A. Goffeau,et al. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals , 1995, Current Genetics.
[163] P. Marichal,et al. Origin of differences in susceptibility of Candida krusei to azole antifungal agents , 1995, Mycoses.
[164] A. Oppenheim,et al. Multidrug resistance in Candida albicans: disruption of the BENr gene , 1995, Antimicrobial agents and chemotherapy.
[165] S. Sternberg. The emerging fungal threat. , 1994, Science.
[166] S. Kelly,et al. Resistance to amphotericin B associated with defective sterol delta 8-->7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. , 1994, FEMS microbiology letters.
[167] J. Becker,et al. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene , 1994, Antimicrobial Agents and Chemotherapy.
[168] P. Troke,et al. Fluconazole resistance in Candida glabrata , 1993, Antimicrobial Agents and Chemotherapy.
[169] J. A. Gorman,et al. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate , 1991, Molecular and General Genetics MGG.
[170] N. Karnani,et al. Identification of a negative regulatory element which regulates basal transcription of a multidrug resistance gene CDR1 of Candida albicans. , 2004, FEMS yeast research.
[171] W. Moye-Rowley. Transcriptional control of multidrug resistance in the yeast Saccharomyces. , 2003, Progress in nucleic acid research and molecular biology.
[172] E. Pinjon. Investigation into the molecular mechanisms of itraconazole resistance in Candida dubliniensis , 2003 .
[173] I. Pastan,et al. Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.
[174] J. F. Ryley,et al. Azole resistance in Candida albicans. , 1984, Sabouraudia.